2008 Update of international guidelines for the management of severe sepsis and septic shock: Should we change our current clinical practice?

Polskie Archiwum Medycyny Wewnetrznej

Volumn 118, Issue 3, 2008, Pages 92-95

  Jaeschke, Roman Z ^a,b   Brozek, Jan L ^b,c,d   Dellinger, R Phillip ^e  

^a MCMASTER UNIVERSITY   (Canada)

^b Polish Institute for Evidence Based Medicine   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^e RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CORTICOSTEROID; DROTRECOGIN; IMMUNOGLOBULIN; PLACEBO;

ANTIMICROBIAL THERAPY; BLOOD TRANSFUSION; CENTRAL VENOUS PRESSURE; CLINICAL FEATURE; CLINICAL PRACTICE; CONFLICT OF INTEREST; EARLY DIAGNOSIS; EARLY INTERVENTION; EDITORIAL; EDUCATION; FLUID RESUSCITATION; GLYCEMIC CONTROL; HEALTH CARE PERSONNEL; HOSPITALIZATION; HUMAN; INFLAMMATION; METHODOLOGY; MORTALITY; OXYGEN SUPPLY; PERFUSION; PRACTICE GUIDELINE; PROGNOSIS; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UNITED STATES; URINE VOLUME;

EID: 41749114059     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.318     Document Type: Editorial

References (17)

1. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003; 31: 1250-1256.
2. Members of the ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992; 20: 864-874.
3. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29: 1303-1310.
4. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2004; 30: 536-555.
5. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008; 36: 296-327.
6. Schünemann HJ, Jaeschke R, Cook DJ, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med. 2006; 174: 605-614.
7. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006; 34: 1589-1596.
8. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001; 345: 1368-1377.
9. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008; 358: 111-124.
10. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001; 344: 699-709.
11. Abraham E, Laterre PF, Garg R, et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med. 2005; 353: 1332-1341.
12. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001; 345: 1359-1367.
13. van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006; 354: 449-461.
14. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008; 358: 125-139.
15. A multi-centre, open label randomised stratified controlled trial of the effects of blood glucose management on 90-day all-cause mortality in a heterogeneous population of intensive care unit (ICU) patients. (Normoglycaemia in Intensive Care Evaluation and Survival Using Glucose Algorithm Regulation - NICE-SUGAR STUDY). http://www.controlled-trials.com/ISRCTN04968275.
16. Kreymann KG, de Heer G, Nierhaus A, et al. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med. 2007; 35: 2677-2685.
17. Winters BD, Pham JC, Hunt EA, et al. Rapid response systems: a systematic review. Crit Care Med. 2007; 35: 1238-1243.